| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/19/2001 | CN1071117C Antitussive |
| 09/19/2001 | CN1071116C Paroxetine tablets and process to prepare them |
| 09/19/2001 | CN1071115C Compound medicine for gastroenteritis and gastroenteritic ulcer |
| 09/19/2001 | CN1071114C Injectable mesna solutions |
| 09/19/2001 | CN1071113C Compositions and processes for the sustained release of drugs |
| 09/19/2001 | CN1071112C Use in preparation of nutrients for skin care from cholesterine and phospholipid and its producing process |
| 09/19/2001 | CA2372450A1 Liquid injectable formulation of disodium pamidronate |
| 09/18/2001 | US6291702 As agents for trapping and identifying free radical species and find use as efficient antioxidants in physicochemical and biological systems. |
| 09/18/2001 | US6291690 Hydrophobic taxane derivatives |
| 09/18/2001 | US6291689 Cyclizing 4-cyano-2-hydroxymethylphenyl)(4-fluorophenyl)methanol to form 1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile; alkylating to form citalopram |
| 09/18/2001 | US6291687 Used aspartyl protease inhibitors of human immunodeficiency virus (hiv) |
| 09/18/2001 | US6291679 Process for preparing benzoperhydroisoindole compounds |
| 09/18/2001 | US6291678 Process for the preparation of chiral keto-heterocycles of basic amino acids |
| 09/18/2001 | US6291672 Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 09/18/2001 | US6291657 N-butyldeoxygalactonojirimycin; suppression of glycolipid biosynthesis; microbiocides; treatment of gaucher's disease |
| 09/18/2001 | US6291534 2,6- and 2,7-dimethoxynaphthalene |
| 09/18/2001 | US6291533 Dietary supplements for each specific blood type |
| 09/18/2001 | US6291532 Use of N-aryl-2-hydroxyalkylamides for stimulating or inducing hair growth and/or arresting hair loss |
| 09/18/2001 | US6291530 Aryl-substituted acrylamides with Leukotriene B4 (LTB-4) receptor antagonist activity |
| 09/18/2001 | US6291528 Prostaglandin E1/F2 in combination with prostaglandin F2α for enhancing female sexual arousal |
| 09/18/2001 | US6291527 Hydrosoluble salts obtained through a reaction between ketoprofen and glucosamine and/or proline and/or hydroxyproline; useful for antiinflammatory and analgesic treatment of joints and mucous membranes. |
| 09/18/2001 | US6291526 Treating a patient having parkinson's disease by administering 4-amino-3-(2-methylpropyl)butanoic acid. |
| 09/18/2001 | US6291525 Administering beta-hydroxy-beta-methylbutyric acid in free acid, salt, ester, or lactone form. |
| 09/18/2001 | US6291524 Hydroxy-, methoxy- and acetoxy-derivatives of 2,3-dimethyl-1,4-diphenylbutane |
| 09/18/2001 | US6291523 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives |
| 09/18/2001 | US6291522 Cyclopentane heptan(ENE)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents |
| 09/18/2001 | US6291521 Anti-portal hypertensive agent |
| 09/18/2001 | US6291520 Hydroxamic acid and N-hydroxyurea derivatives and their use |
| 09/18/2001 | US6291519 Method of preventing damage to eye tissue |
| 09/18/2001 | US6291518 Hydroxy and polyhydroxy derivatives of coumarin, preparation thereof and antiviral action thereof |
| 09/18/2001 | US6291517 Method for preventing or reducing stress-induced gastric injury using grape seed proanthocyanidin extract |
| 09/18/2001 | US6291516 Contacting the cell with a composition including at least one cyclic amp agonist. |
| 09/18/2001 | US6291509 Synergistic immunosuppressant composition containing a 2,2'-bi-1H-pyrrole compound |
| 09/18/2001 | US6291507 Chemical compounds |
| 09/18/2001 | US6291506 Method of reducing retinal ganglion cell degeneration |
| 09/18/2001 | US6291505 Pyrazole estrogen receptor agonist and antagonist |
| 09/18/2001 | US6291503 β-phenylalanine derivatives as integrin antagonists |
| 09/18/2001 | US6291502 Use of 2-imidazolyl-substituted carbinols for the production of a medicament for the treatment or phophylaxis of diseases caused by ischemic conditions |
| 09/18/2001 | US6291501 Specifically exemplified herein are dragmacidin f, topsentin d, and topsentin e, and their salts, analogs, and derivatives. |
| 09/18/2001 | US6291500 Administering an antifungal agent |
| 09/18/2001 | US6291499 2-cyclohexyl benzimidazole NMDA/NR2B antagonists |
| 09/18/2001 | US6291498 Method for optimizing pupil size using alpha antagonist |
| 09/18/2001 | US6291494 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use |
| 09/18/2001 | US6291493 Use of clomethiazole and salts |
| 09/18/2001 | US6291490 Methods and compositions for treating conditions caused by excessive calcium influx in cells using optically pure (-) amlodipine |
| 09/18/2001 | US6291489 Process for substituted pyridines |
| 09/18/2001 | US6291488 Administering 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone and 1-(4-chlorophenyl)-5-isopropylbiguanide hydrochloride in a ratio of 1:1 to 3:1. |
| 09/18/2001 | US6291487 Thiazoles substituted with a phenyl and a pyridyl group |
| 09/18/2001 | US6291486 Polycyclic Dihydrothiazoles, their preparation and use as pharmaceuticals |
| 09/18/2001 | US6291485 Treatment of post-ptca restenosis |
| 09/18/2001 | US6291484 Treatment of the various medical conditions associated with postmenopausal syndrome |
| 09/18/2001 | US6291483 Administering a therapeutically effective amount of berberine or a pharmaceutically acceptable salt thereof |
| 09/18/2001 | US6291481 Conditions related to a hampered or impaired gastric emptying and more generally to treat conditions related to a hampered or impaired gastrointestinal transit. |
| 09/18/2001 | US6291480 Diaryl piperidyl pyrrole derivatives as antiprotozoal agents |
| 09/18/2001 | US6291479 Use of NR2B-selective NMDA-receptor antagonists for the treatment of ophthalmic diseases |
| 09/18/2001 | US6291478 Compounds of the benzylaminodiacetamide family, compositions comprising them, preparation process and uses |
| 09/18/2001 | US6291477 Tetrahydroquinolines, processes for their preparation, pharmaceutical compositions containing them, and their use to prevent or treat hyperlipoproteinaemia |
| 09/18/2001 | US6291475 Bispidine antiarrhythmic compounds |
| 09/18/2001 | US6291474 Bicyclic amine derivatives |
| 09/18/2001 | US6291473 Treating anxiety, depression, post-traumatic stress disorder, inflammatory diseases, obesity, in mammals |
| 09/18/2001 | US6291472 4a, 5a, 8a, 8b-tetrahydro-6H-pyrrolo[3′,4′:4, 5]furo[3,2-b] pyri-dine-6,8(7H)-dione derivatives for control of endoparasites processes for their preparation |
| 09/18/2001 | US6291471 Use of apomorphine for the treatment of organic erectile dysfunction in males |
| 09/18/2001 | US6291470 Indole derivatives process for producing the same and medicinal uses of the same |
| 09/18/2001 | US6291469 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 09/18/2001 | US6291468 Pyrimidine 3-oxide compounds for inducing/stimulating hair growth and/or retarding hair loss |
| 09/18/2001 | US6291466 Cholinergic agents in the treatment of presbyopia |
| 09/18/2001 | US6291465 Biphenyl derivatives |
| 09/18/2001 | US6291464 Aminopiperazine derivatives |
| 09/18/2001 | US6291462 Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates |
| 09/18/2001 | US6291461 Stephacidin antitumor antibiotics |
| 09/18/2001 | US6291460 Treatment of anxiety; treatment and/or prevention of convulsions |
| 09/18/2001 | US6291459 Calcilytic compounds |
| 09/18/2001 | US6291458 Morpholinobenzamide salts |
| 09/18/2001 | US6291457 Compounds having cytokine inhibitory activity |
| 09/18/2001 | US6291455 Producing an antiangiogenic and/or vascular permeability reducing effect |
| 09/18/2001 | US6291454 Dithiepino[6,5-b]pyridines, and related compositions and methods |
| 09/18/2001 | US6291452 Cholecystokinin antagonists. |
| 09/18/2001 | US6291451 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 09/18/2001 | US6291450 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 09/18/2001 | US6291449 Use of 11-phenyl-dibenzazepine compounds to treat diarrhea or scours |
| 09/18/2001 | US6291448 Carbapenem antibacterial compounds, compositions containing such compounds and method of treatment |
| 09/18/2001 | US6291446 Particularly using the isozyme selective pkc inhibitor, (s)-3,4-(n,n'-1,1'-((2?-ethoxy)-3'?(o)-4'?-(n, n-dimethylamino)-butane)-bis-(3,3'-indolyl))-1(h)-pyrrole-2,5-dione hydrochloride salt. |
| 09/18/2001 | US6291445 For the treatment of conditions of the nose. |
| 09/18/2001 | US6291444 Treatment of t-cell immunodeficiencies with vitamin D compounds |
| 09/18/2001 | US6291443 Method of preventing and treating chemotherapy-induced alopecia with vitamin D3 or a derivative or analog or active metabolite thereof. |
| 09/18/2001 | US6291442 Pharmacological modulators of voltage-gated potassium ion channels |
| 09/18/2001 | US6291441 Administering a thiol or reducible disulfide compound |
| 09/18/2001 | US6291437 The protein/nucleic acid compositions are administered in an amount capable of inducing cell mediated immunity and/or antibody response in the subject. |
| 09/18/2001 | US6291435 Reduce the virulence of an epec organism, which method comprises contacting an epec organism with a composition comprising a monosaccharide or an oligosaccharide sequence |
| 09/18/2001 | US6291425 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 09/18/2001 | US6291211 Expressing heterologous polypeptides in cells; incubate cells with expression vectors, transform cells, express heterologous polypeptide |
| 09/18/2001 | US6291199 Human phosphodiesterase type IVC, and its production and use |
| 09/18/2001 | US6291195 Generating ligands which bind preferential human receptors; incubate cells expressing preferential binding protein with modulator, detect adjustment in binding activity |
| 09/18/2001 | US6291175 Methods for treating a neurological disease by determining BCHE genotype |
| 09/18/2001 | US6290996 Administering an extract blend of the fruit of the emblica officinalis plant |
| 09/18/2001 | US6290994 Beverage containing caffeine or theobromine and vinpocetine citrate for stimulating cerebral activity |
| 09/18/2001 | US6290993 Compositions containing mimosa phenolic compounds |
| 09/18/2001 | US6290983 Preparation of biodegradable, biocompatible microparticles containing a biologically active agent |
| 09/18/2001 | US6290981 Use of nitric oxide-releasing agents to treat impotency |
| 09/18/2001 | US6290965 DNA encoding human papillomavirus type 6A |